BioVector® 淋球菌 WHO 表达与耐药质控标准株系档案 / BioVector® Neisseria gonorrhoeae WHO Reference Strain Panel

背景与来源说明 / Context & Provenance: 本标准品株系集由世界卫生组织（WHO）与英国国家菌种保藏中心（NCTC）联合确立，属于国际淋球菌抗微生物药物耐药性监测（WHO GASP / EGASP）与体外诊断（IVD / AST）的标准质控株。BioVector® 收集并整理该批耐药与敏感表型明确的标准菌株（NCTC 13477、13820、13483、14208、13818），专用于表型药敏试验（琼脂稀释法、Etest）、基因检测（NAAT / PCR）及全基因组测序（WGS）质控。

标准菌株特征与耐药表型汇总表 / Strain Phenotype & AMR Matrix

培养与复苏操作规范 / Cultivation & Handling Guidelines

1. 培养基与环境条件

• 推荐培养基：GC 琼脂基础（GC Agar Base）添加 1% IsoVitaleX 或 Kellogg 营养添加剂；或巧克力琼脂平板（Chocolate Agar）。

• 培养温度：35 - 37 deg C。

• 气体环境：3% - 5% CO2 湿润环境（或使用二氧化碳培养箱 / 烛缸）。

• 生物安全等级：BSL-2（第二类危险微生物）。

2. 复苏与保存规范

• 冻干株/冻存株复苏：接种于预温的巧克力琼脂平板，划线分离单菌落，在 35-37 deg C、5% CO2 下培养 18-24 小时。淋球菌对干燥和低温极敏感，切勿置于 4 deg C 冰箱过夜保存。

• 菌种保存：短期保存需每日传代；长期保存建议使用含 15%-20% 甘油的胰蛋白胨大豆肉汤（TSB）或脱脂牛奶，于 -80 deg C 深低温冻存。

标准应用场景 / Key Standard Applications

1. 抗微生物药物敏感性试验（AST）质控

   • 用于琼脂稀释法（Agar Dilution）、纸片扩散法（Disk Diffusion）及 Etest 梯度条测定头孢曲松、阿奇霉素、环丙沙星、大观霉素等药物 MIC 值的质量控制。

2. 分子诊断（NAAT / PCR）与基因测序质控

   • 作为检测耐药基因突变（如 penA 嵌合体、23S rRNA A2059G、gyrA S91F、blaTEM）的标准阳性/阴性对照。

3. 全球与国家级监测项目（GASP / GISP）

   • 作为不同实验室间数据比对与质量评估（EQA / PT）的统一参考基准。

BioVector® Neisseria gonorrhoeae WHO Reference Strain Panel

General Overview

This reference strain panel represents the official World Health Organization (WHO) 2008/2016 Neisseria gonorrhoeae reference strain set, deposited under the National Collection of Type Cultures (NCTC). Maintained and distributed for standardized quality control, these strains (NCTC 13477, 13820, 13483, 14208, 13818) cover a well-defined spectrum of antimicrobial susceptibility and resistance profiles for AST assay calibration, molecular diagnostics (NAAT/PCR), and Whole Genome Sequencing (WGS) benchmarking.

Technical & Phenotypic Specifications

1. Strain Characterization Matrix

• WHO F (NCTC 13477)

  • Phenotype: Fully susceptible reference control strain.

  • Key Profile: Low MICs to Penicillin, Ceftriaxone, Cefixime, Azithromycin, Ciprofloxacin, and Spectinomycin.

  • Application: Baseline reference for MIC determination and culture media QC.

• WHO X (NCTC 13820)

  • Phenotype: Extensively Drug-Resistant Neisseria gonorrhoeae (XDR-NG).

  • Key Profile: Decreased susceptibility/resistance to Extended-Spectrum Cephalosporins (ESC; Ceftriaxone, Cefixime), fluoroquinolones, and penicillins. Driven by mosaic penA XXXIV allele and mtrR promoter mutations.

  • Application: QC control for cephalosporin resistance surveillance and ESBL/ESC detection assays.

• WHO O (NCTC 13483)

  • Phenotype: High-Level Azithromycin Resistant strain (HLAzR).

  • Key Profile: Azithromycin MIC > 256 ug/mL due to homozygous A2059G mutation in all 4 copies of 23S rRNA.

  • Application: QC standard for macrolide resistance assays and A2059G point-mutation molecular screening.

• WHO Q (NCTC 14208)

  • Phenotype: Multidrug-resistant strain (MDR-NG / PPNG).

  • Key Profile: Resistant to Penicillin, Tetracycline, and Ciprofloxacin; carries plasmid-mediated beta-lactamase (blaTEM).

  • Application: QC control for plasmid-mediated penicillinase production and fluoroquinolone target mutations (gyrA/parC).

• WHO V (NCTC 13818)

  • Phenotype: ESC decreased susceptibility reference strain.

  • Key Profile: Intermediate/elevated MICs for Cefixime and Ceftriaxone via non-mosaic/mosaic penA variants combined with porB1b (penB) efflux/influx alterations.

  • Application: MIC cut-off validation for oral/injectable cephalosporins in clinical AST workflows.

2. Recommended Culture & Growth Protocols

• Growth Medium: GC Agar base supplemented with 1% IsoVitaleX / Kellogg's supplement, or Chocolate Agar.

• Incubation Conditions: 35 - 37 deg C under 3% - 5% CO2 in a humidified atmosphere for 18 - 24 hours.

• Handling Note: Fastidious organism; highly sensitive to desiccation, temperature drops, and autolysis. Do not store live cultures at 4 deg C.

• Biosafety Level: Biosafety Level 2 (BSL-2).

Technical Specifications Table

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

电话:400-800-2947

工作QQ/微信同号:1843439339

E-mail:BioVector@163.com

网址http://www.biovector.net